Cytochrome P450 gene polymorphism and cancer

Current Drug Metabolism

Volumn 5, Issue 3, 2004, Pages 211-224

  Agúndez, José A G ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Cancer; Cytochrome P450; Polymorphisms; Susceptibility

Indexed keywords

1 NITROSOPIPERIDINE; 1,3 BUTADIENE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ANABASINE DERIVATIVE; CYCLOPHOSPHAMIDE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; DICHLOBENIL; DIETHYLNITROSAMINE; ESTRONE; HETEROCYCLIC AMINE; N NITROSOPYRROLIDINE; NITROSAMINE; NITROSONORNICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYCYCLIC HYDROCARBON; RETROVIRUS VECTOR; STEROID 21 MONOOXYGENASE;

ANUS CANCER; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; COLORECTAL CANCER; DISEASE ASSOCIATION; DRUG METABOLISM; ENZYME ACTIVITY; ESOPHAGUS CANCER; GENE DELETION; GENE DUPLICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTOXICITY; GENOTYPE; HEAD AND NECK CANCER; HUMAN; HYPOPHYSIS TUMOR; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; MELANOMA; METHODOLOGY; OVARY CANCER; PANCREAS CANCER; PHENOTYPE; PROSTATE CANCER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TOXICOKINETICS; UTERINE CERVIX CANCER; VULVA CANCER;

CLINICAL TRIALS; CYTOCHROME P-450 ENZYME SYSTEM; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 2942598063     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200043335621     Document Type: Review

References (281)

1. Ingelman-Sundberg, M. (2002) Toxicology, 181-182, 447-452.
2. Kamataki, T.; Fujita, K.; Nakayama, K.; Yamazaki, Y.; Miyamoto, M.; and Ariyoshi, N. (2002) Drug. Metab. Rev., 34(3), 667-76.
3. Williams, J.A. (2001) Carcinogenesis, 22(2), 209-214.
4. Bartsch, H.; Rojas, M.; Alexandrov, K.; Camus, A.M.; Castegnaro, M.; Malaveille, C.; Anttila, S.; Hirvonen, K.; Husgafvel-Pursiainen, K. and Hietanen, E. (1995) Pharmacogenetics, 5 Spec No), S84-90.
5. Ikawa, S.; Uematsu, F.; Watanabe, K.; Kimpara, T.; Osada, M.; Hossain, A.; Sagami, I.; Kikuchi, H. and Watanabe, M. (1995) Pharmacogenetics, 5 Spec No, S154-160.
6. Spurr, N.K.; Gough, A.C.; Stevenson, K. and Wolf, C.R. (1987) Nucleic Acids Res., 15(14), 5901.
7. Hayashi, S.; Watanabe, J.; Nakachi, K. and Kawajiri, K. (1991) J. Biochem. (Tokyo), 110(3), 407-411.
8. Petersen, D.D.; McKinney, C.E.; Ikeya, K.; Smith, H.H.; Bale, A.E.; McBride, O.W. and Nebert, D.W. (1991) Am. J. Hum. Genet., 48(4), 720-725.
9. Kiyohara, C.; Hirohata, T. and Inutsuka, S. (1996) Jpn. J. Cancer Res., 87(1), 18-24.
10. Wedlund, P.J.; Kimura, S.; Gonzalez, F.J. and Nebert, D.W. (1994) Pharmacogenetics, 4(1), 21-26.
11. Jacquet, M.; Lambert, V.; Baudoux, E.; Muller, M.; Kremers, P. and Gielen, J. (1996) Eur. J. Cancer, 32A(10), 1701-1706.
12. Anttila, S.; Tuominen, P.; Hirvonen, A.; Nurminen, M.; Karjalainen, A.; Hankinson, O. and Elovaara, E. (2001) Pharmacogenetics, 11(6), 501-509.
13. Smith, G.B.; Harper, P.A.; Wong, J.M.; Lam, M.S.; Reid, K.R.; Petsikas, D. and Massey, T.E. (2001) Cancer Epidemiol. Biomarkers Prev., 10(8), 839-853.
14. Kellermann, G.; Shaw, C.R.; Luyten, W. and Luyten, K.M. (1973) New Engl. J. Med., 289, 934-937.
15. Houlston, R.S. (2000) Pharmacogenetics, 10(2), 105-114.
16. Vineis, P.; Veglia, F.; Benhamou, S.; Butkiewicz, D.; Cascorbi, I.; Clapper, M.L.; Dolzan, V.; Haugen, A.; Hirvonen, A.; Ingelman-Sundberg, M.; Kihara, M.; Kiyohara, C.; Kremers, P.; Le Marchand, L.; Ohshima, S.; Pastorelli, R.; Rannug, A.; Romkes, M.; Schoket, B.; Shields, P.; Strange, R.C.; Stucker, I.; Sugimura, H.; Garte, S.; Gaspari, L. and Taioli, E. (2003) Int. J. Cancer, 104(5), 650-657.
17. Taioli, E.; Gaspari, L.; Benhamou, S.; Boffletta, P.; Brockmoller, J.; Butkiewicz, D.; Cascorbi, I.; Clapper, M.L.; Dolzan, V.; Haugen, A.; Hirvonen, A.; Husgafvel-Pursiainen, K.; Kalina, I.; Kremers, P.; Le Marchand, L.; London, S.; Rannug, A.; Romkes, M.; Schoket, B.; Seidegard, J.; Strange, R.C.; Stucker, I.; To-Figueras, J. and Garte, S. (2003) Int. J. Epidemiol., 32(1), 60-63.
18. Kao, S.Y.; Wu, C.H.; Lin, S.C.; Yap, S.K.; Chang, C.S.; Wong, Y.K.; Chi, L.Y. and Liu, T.Y. (2002) J. Oral. Palhol. Med, 31(9), 505-511.
19. Sreelekha, T.T.; Ramadas, K.; Pandey, M.; Thomas, G.; Nalinakumari, K.R. and Pillai, M.R. (2001) Oral. Oncol., 37(7), 593-598.
20. Sato, M.; Sato, T.; Izumo, T. and Amagasa, T. (2000) Oral. Oncol., 36(3), 267-271.
21. Tanimoto, K.; Hayashi, S.; Yoshiga, K. and Ichikawa, T. (1999) Oral. Oncol., 35(2), 191-196.
22. Morita, S.; Yano, M.; Tsujinaka, T.; Akiyama, Y.; Taniguchi, M.; Kaneko, K.; Miki, H.; Fujii, T.; Yoshino, K.; Kusuoka, H. and Monden, M. (1999) Int. J. Cancer, 80(5), 685-688.
23. Park, J.Y.; Muscat, J.E.; Ren, Q.; Schantz, S.P.; Harwick, R.D.; Stern, J.C.; Pike, V.; Richie, J.P. Jr. and Lazarus, P. (1997) Cancer Epidemiol. Biomarkers Prev., 6(10), 791-797.
24. Hahn, M.; Hagedorn, G.; Kuhlisch, E.; Schackert, H.K. and Eckelt, U. (2002) Oral. Oncol., 38(5), 486-490.
25. Ko, Y.; Abel, J.; Harth, V.; Brode, P.; Antony, C.; Donat, S.; Fischer, H.P.; Ortiz-Pallardo, M.E.; Thier, R.; Sachinidis, A.; Vetter, H.; Bolt, H.M.; Herberhold, C. and Bruning, T. (2001) Cancer Res., 61(11), 4398-4404.
26. McWilliams, J.E.; Evans, A.J.; Beer, T.M.; Andersen, P.E.; Cohen, J.I.; Everts, E.C. and Henner, W.D. (2000) Head Neck., 22(6), 609-617.
27. Olshan, A.F.; Weissler, M.C.; Watson, M.A. and Bell, D.A. (2000) Cancer Epidemiol. Biomarkers Prev., 9(2), 185-191.
28. Katoh, T.; Kaneko, S.; Kohshi, K.; Munaka, M.; Kitagawa, K.; Kunugita, N.; Ikemura, K. and Kawamoto, T. (1999) Int. J. Cancer, 83(5), 606-609.
29. Matthias, C.; Bockmuhl, U.; Jahnke, V.; Harries, L.W.; Wolf, C.R.; Jones, P.W.; Alldersea, J.; Worrall, S.F.; Hand, P.; Fryer, A.A. and Strange, R.C. (1998) Pharmacogenetics, 8(1), 1-6.
30. Worrall, S.F.; Corrigan, M.; High, A.; Starr, D.; Matthias, C.; Wolf, C.R.; Jones, P.W.; Hand, P.; Gilford, J.; Farrell, W.E.; Hoban, P.; Fryer, A.A. and Strange, R.C. (1998) Pharmacogenetics, 8(5), 433-439.
31. Oude Ophuis, M.B.; van Lieshout, E.M.; Roelofs, H.M.; Peters, W.H. and Manni, J.J. (1998) Cancer, 82(5), 936-943.
32. Jahnke, V.; Strange, R.; Matthias, C. and Fryer, A. (1997) Eur Arch Otorhinolaryngol, 254 (Suppl. 1), S147-149.
33. Lucas, D.; Menez, C.; Floch, F.; Gourlaouen, Y.; Sparfel, O.; Joannet, I.; Bodenez, P.; Jezequel, J.; Gouerou, H.; Berthou, F.; Bardou, L.G. and Menez, J.F. (1996) Alcohol. Clin. Exp. Res., 20(6), 1033-1037.
34. Nimura, Y.; Yokoyama, S.; Fujimori, M.; Aoki, T.; Adachi, W.; Nasu, T.; He, M.; Ping, Y.M. and Iida, F. (1997) Cancer, 80(5), 852-857.
35. Wu, M.T.; Lee, J.M.; Wu, D.C.; Ho, C.K.; Wang, Y.T.; Lee, Y.C.; Hsu, H.K. and Kan, E.L. (2002) Br. J. Cancer, 87(5), 529-532.
36. Wang, A.H.; Sun, C.S.; Li, L.S.; Huang, J.Y. and Chen, Q.S. (2002) World J. Gastroenterol., 8(1), 49-53.
37. Roth, M.J.; Dawsey, S.M.; Wang, G.; Tangrea, J.A.; Zhou, B.; Ratnasinghe, D.; Woodson, K.G,: Olivero, O.A.; Poirier, M.C.; Frye, B.L.; Taylor, P.R. and Weston, A. (2000) Cancer Lett., 156(1), 73-81.
38. Hori, H.; Kawano, T.; Endo, M. and Yuasa, Y. (1997) J. Clin. Gastroenterol., 25(4), 568-575.
39. Morita, S.; Yano, M.; Shiozaki, H.; Tsujinaka, T.; Ebisui, C.; Morimoto, T.; Kishibuti, M.; Fujita, J.; Ogawa, A.; Taniguchi, M.; Inoue, M.; Tamura, S.; Yamazaki, K.; Kikkawa, N.; Mizunoya, S. and Monden, M. (1997) Int. J. Cancer, 71 (2); 192-195.
40. Ye, Z. and Parry, J.M. (2002) Teratog. Carcinog. Mulagen., 22(5), 385-392.
41. Hiratsuka, M.; Takekuma, Y.; Endo, N.; Narahara, K.; Hamdy, S.I.; Kishikawa, Y.; Matsuura, M.; Agatsuma, Y.; Inoue, T. and Mizugaki, M. (2002) Eur. J. Clin. Pharmacol., 58(6), 417-421.
42. Kiss, I.; Sandor, J.; Pajkos, G.; Bogner, B.; Hegedus, G. and Ember, I. (2000) Anticancer Res., 20(1B), 519-522.
43. Sachse, C.; Smith, G.; Wilkie, M.J.; Barrett, J.H.; Waxman, R.; Sullivan, F.; Forman, D.; Bishop, D.T. and Wolf, C.R. (2002) Carcinogenesis, 23(11), 1839-1849.
44. Silvestri, L.; Sonzogni, L.; De Silvestri, A.; Gritti, C.; Foti, L.; Zavaglia, C.; Leveri, M.; Cividini, A.; Mondelli, M.U.; Civardi, E. and Silini, E.M. (2003) Int. J. Cancer, 104(3), 310-317.
45. Yu, M.W.; Chiu, Y.H.; Yang, S.Y.; Santella, R.M.; Chern, H.D.; Liaw, Y.F. and Chen, C.J. (1999) Br. J. Cancer, 80(3-4), 598-603.
46. Duell, E.J.; Holly, E.A.; Bracci, P.M.; Liu, M.; Wiencke, J.K. and Kelsey, K.T. (2002) J. Natl. Cancer Inst., 94(4), 297-306.
47. Liu, G.; Ghadirian, P.; Vesprini, D.; Hamel, N.; Paradis, A.J.; Lal, G.; Gallinger, S.; Narod, S.A. and Foulkes, W.D. (2000) Br. J. Cancer, 82(10), 1646-1649.
48. Lee, H.C.; Yoon, Y.B. and Kim, C.Y. (1997) Korean. J. Intern. Med., 12(2), 128-136.
49. Tsuchiya, Y.; Sato, T.; Kiyohara, C.; Yoshida, K.; Ogoshi, K.; Nakamura, K. and Yamamoto, M. (2002) J. Exp. Clin. Cancer Res., 21(1), 119-124.
50. Da Fonte de Amorim, L.; Rossini, A.; Mendonca, G.; Lotsch, P.; de Almeida Simao, T.; de Moura Gallo, C. and Pinto, L. (2002) Cancer Lett., 18(2), 179-186.
51. Miyoshi, Y.; Takahashi, Y.; Egawa, C. and Noguchi, S. (2002) Breast J., 8(4), 209-215.
52. Krajinovic, M.; Ghadirian, P.; Richer, C.; Sinnett, H.; Gandini, S.; Perret, C.; Lacroix, A.; Labuda, D. and Sinnett, D. (2001) Int. J. Cancer, 92(2). 220-225.
53. Taioli, E.; Bradlow, H.L.; Garbers, S.V.; Sepkovic, D.W.; Osborne, M.P.; Trachman, J.; Ganguly, S. and Garte, S.J. (1999) Cancer Detect Prev., 23(3), 232-237.
54. Huang, C.S.; Shen, C.Y.; Chang, K.J.; Hsu, S.M. and Chern, H.D. (1999) Br. J. Cancer, 80(11), 1838-1843.
55. Fontana, X.; Peyrottes, I.; Rossi, C.; Leblanc-Talent, P.; Ettore, F.; Namer, M. and Bussiere, F. (1998) Mutat. Res., 403(1-2), 45-53.
56. Laden, F.; Ishibe, N.; Hankinson, S.E.; Wolff, M.S.; Gertig, D.M.; Hunter, D.J. and Kelsey, K.T. (2002) Cancer Epidemiol. Biomarkers Prev., 11(12), 1560-1565.
57. Wu, F.Y.; Lee, Y.J.; Chen, D.R. and Kuo, H.W. (2002) Mutat. Res., 501(1-2), 69-78.
58. Basham, V.M.; Pharoah, P.D.; Healey, C.S.; Luben, R.N.; Day, N.E.; Easton, D.F.; Ponder, B.A. and Dunning, A.M. (2001) Carcinogenesis, 22(11), 1797-1800.
59. Dialyna, I.A.; Arvanitis, D.A. and Spandidos, D.A. (2001) Int. J. Mol. Med., 8(1), 79-87.
60. Moysich, K.B.; Shields, P.G.; Freudenheim, J.L.; Schisterman, E.F.; Vena, J.E.; Kostyniak, P.; Greizerstein, H.; Marshall, J.R.; Graham, S. and Ambrosone, C.B. (1999) Cancer Epidemiol. Biomarkers Prev., 8(1), 41-44.
61. Ishibe, N.; Hankinson, S.E.; Colditz, G.A.; Spiegelman, D.; Willett, W.C.; Speizer, F.E.; Kelsey, K.T. and Hunter, D.J. (1998) Cancer Res., 58(4), 667-671.
62. Bailey, L.R.; Roodi, N.; Verrier, C.S.; Yee, C.J.; Dupont, W.D. and Parl, F.F. (1998) Cancer Res., 58(1), 65-70.
63. Ambrosone, C.B.; Freudenheim, J.L.; Graham, S.; Marshall, J.R.; Vena, J.E.; Brasure, J.R.; Laughlin, R.; Nemoto, T.; Michalek, A.M. and Harrington, A. (1995) Cancer Res., 55(16), 3483-3485.
64. Brockmoller, J.; Cascorbi, I.; Kerb, R. and Roots, I. ( 1996) Cancer Res., 56(17), 3915-3925.
65. Murata, M.; Watanabe, M.; Yamanaka, M.; Kubota, Y.; Ito, H.; Nagao, M.; Katoh, T.; Kamataki, T.; Kawamura. J.; Yatani, R. and Shiraishi, T. (2001) Cancer Lett., 165(2), 171-177.
66. Murata, M.; Shiraishi, T.; Fukutome, K.; Watanabe, M.; Nagao, M.; Kubota, Y.; Ito, H.; Kawamura, J. and Yatani, R. (1998) Jpn. J. Clin. Oncol., 28(11), 657-660.
67. Aktas, D.; Guney, I.; Alikasifoglu, M.; Yuce, K.; Tuncbilek, E. and Ayhan, A. (2002) Gynecol. Oncol., 86(2), 124-128.
68. Goodman, M.T.; McDuffie, K.; Kolonel, L.N.; Terada, K.; Donlon, T.A.; Wilkens, L.R.; Guo, C. and Le Marchand, L. (2001) Cancer Epidemiol. Biomarkers Prev., 10(3), 209-216.
69. Longuemaux, S.; Delomenie, C.; Gallou, C.; Mejean, A.; Vincent-Viry, M.; Bouvier, R.; Droz, D.; Krishnamoorthy, R.; Galteau, M.M.; Junien, C.; Beroud. C. and Dupret, J.M. (1999) Cancer Res., 59(12), 2903-2908.
70. Esteller, M.; Garcia, A.; Martinez-Palones, J.M.; Xercavins, J. and Reventos, J. (1999) Int. J. Gynecol. Pathol., 18(4), 387-391.
71. Goodman, M.T.; McDuffie, K.; Hernandez, B.; Bertram, C.C.; Wilkens, L.R.; Guo, C.; Seifried, A.; Killeen, J. and Le Marchand, L. (2001) Gynecol. Oncol., 81(2), 263-269.
72. Kim, J.W.; Lee, C.G.; Park, Y.G.; Kim, K.S.; Kim, I.K.; Sohn, Y.W.; Min, H.K.; Lee, J.M. and Namkoong, S.E. (2000) Cancer. 88(9), 2082-2091.
73. Soucek, P.; Sarmanova, J.; Kristensen, V.N.; Apltauerova, M. and Gut, I. (2002) Int. Arch. Occup. Environ. Health, 75 (Suppl.), S86-92.
74. Kerridge, I.; Lincz, L.; Scorgie, F.; Hickey, D.; Granter, N. and Spencer, A. (2002) Br. J. Haematol., 118(2), 477-481.
75. Soucek, P. (2001) Cent. Eur. J. Public. Health., 9(2), 74-78.
76. Sarmanova, J.; Benesova, K.; Gut, I.; Nedelcheva-Kristensen, V.; Tynkova, L. and Soucek, P. (2001) Hum. Mol. Genet., 10(12), 1265-1273.
77. Krajinovic, M,; Richer, C.; Sinnett, H.; Labuda, D. and Sinnett, D. (2000) Cancer Epidemiol. Biomarkers Prev., 9(6), 557-562.
78. Krajinovic, M.; Labuda, D.; Richer, C.; Karimi, S. and Sinnett, D. (1999) Blood, 93(5), 1496-1501.
79. Bowen, D.T.; Frew, M.E.; Rollinson, S.; Roddam, P.L.; Dring, A.; Smith, M.T.; Langabeer, S.E. and Morgan, G.J. (2003) Blood, 101(7), 2770-2774.
80. Roddam, P.L.; Rollinson, S.; Kane, E.; Roman, E.; Moorman, A.; Cartwright, R. and Morgan, G.J. (2000) Pharmacogenetics, 10(7), 605-615.
81. Agundez, J.A.; Gallardo, L.; Martinez, C.; Gervasini, G. and Benitez, J. (1998) Pharmacogenetics, 8(3); 251-258.
82. Hammons, G.J.; Yan-Sanders, Y.; Jin, B.; Blann, E.; Kadlubar, F.F. and Lyn-Cook, B.D. (2001) Life Sci., 69(7), 839-845.
83. Landi, M.T.; Sinha, R.; Lang, N.P. and Kadlubar, F.F. (1999) IARC Sci. Publ., (148), 173-195.
84. Probst-Hensch, N.M.; Tannenbaum, S.R.; Chan, K.K.; Coetzee, G.A.; Ross, R.K. and Yu, M.C. (1998) Cancer Epidemiol. Biomarkers Prev., 7(7), 635-638.
85. MacLeod, S.; Sinha, R.; Kadlubar, F.F. and Lang, N.P. (1997) Mutat. Res., 376(1-2), 135-142.
86. Gago-Dominguez, M.; Bell, D.A.; Watson, M.A.; Yuan, J.M.; Castelao, J.E.; Hein, D.W.; Chan, K.K.; Coetzee, G.A.; Ross, R.K. and Yu, M.C. (2003) Carcinogenesis, 24(3), 483-489.
87. Vaziri, S.A.; Hughes, N.C.; Sampson, H.; Darlington, G.; Jewett, M.A. and Grant, D.M. (2001) Pharmacogenetics, 11(1), 7-20.
88. Lee, S.W.; Jang, I.J.; Shin, S.G.; Lee, K.H.; Yim, D.S. Kim, S.W.; Oh, S.J. and Lee, S.H. (1994) J. Korean. Med. Sci., 9(6), 482-489.
89. Sachse, C.; Bhambra, U.; Smith, G.; Lightfoot, T.J.; Barrett, J.H.; Scollay, J.; Garner, R.C.; Boobis, A.R.; Wolf, C.R. and Gooderham, N.J. (2003) Br. J. Clin. Pharmacol., 55(1), 68-76.
90. Ishibe, N.; Sinha, R.; Hein, D.W.; Kulldorff, M.; Strickland, P.; Fretland, A.J.; Chow, W.H.; Kadlubar, F.F.; Lang, N.P. and Rothman, N. (2002) Pharmacogenetics, 12(2), 145-150.
91. Le Marchand, L.; Hankin, J.H.; Wilkens, L.R.; Pierce, L.M.; Franke, A.; Kolonel, L.N.; Seifried, A.; Custer, L.J.; Chang, W.; Lum-Jones, A. and Donlon, T. (2001) Cancer Epidemiol. Biomarkers Prev., 10(12); 1259-1266.
92. Seow, A.; Zhao, B.; Lee, E.J.; Poh, W.T.; Teh, M.; Eng, P.; Wang, Y.T.; Tan, W.C. and Lee, H.P. (2001) Carcinogenesis, 22(4), 673-677.
93. Stoilov, I.; Akarsu, A.N.; Alozie, I.; Child, A.; Barsoum-Homsy, M.; Turacli, M.E.; Or, M.; Lewis, R.A.; Ozdemir, N.; Brice, G.; Aktan, S.G.; Chevrette, L.; Coca-Prados, M. and Sarfarazi, M. (1998) Am. J. Hum. Genet., 62(3). 573-584.
94. McLellan, R.A.; Oscarson, M.; Hidestrand, M.; Leidvik, B.; Jonsson, E.; Otter, C. and Ingelman-Sundberg, M. (2000) Arch. Biochem. Biophys., 378(1), 175-181.
95. Bailey, L.R.; Roodi, N.; Dupont, W.D. and Parl, F.F. (1998) Cancer Res., 58(22), 5038-5041.
96. Murray, G.I.; Taylor, M.C.; McFadyen, M.C.; McKay, J.A; Greenlee, W.F.; Burke, M.D. and Melvin, W.T. (1997) Cancer Res., 57(14), 3026-3031.
97. McKay, J.A.; Melvin, W.T.; Ah-See, A.K.; Ewen, S.W.; Greenlee, W.F.; Marcus, C.B.; Burke, M.D. and Murray, G.I. (1995) FEBS. Lett., 374(2), 270-272.
98. Dong, Z. (2003) Mutat. Res., 523-524), 145-150.
99. Potter, G.A.; Patterson, L.H.; Wanogho, E.; Perry, P.J.; Butler, P.C.; Ijaz, T.; Ruparelia, K.C.; Lamb, J.H.; Farmer, P.B.; Stanley, L.A. and Burke, M.D. (2002) Br. J. Cancer, 86(5), 774-778.
100. Mollerup, S.; Ovrebo, S. and Haugen, A. (2001) Int. J. Cancer, 92(1), 18-25.
101. Hayes, C.L.; Spink, D.C.; Spink, B.C.; Cao, J.Q.; Walker, N.J. and Sutter, T.R. (1996) Proc. Natl. Acad. Sci. USA. 93(18), 9776-9781.
102. Lee, K.M.; Abel, J.; Ko, Y.; Harth, V.; Park, W.Y.; Seo, J.S.; Yoo, K.Y.; Choi, J.Y.; Shin, A.; Ahn, S.H.; Noh, D.Y.; Hirvonen, A. and Kang, D. (2003) Br. J. Cancer, 88(5), 675-678.
103. De Vivo, I.; Hankinson, S.E.; Li, L.; Colditz, G.A. and Hunter, D.J. (2002) Cancer Epidemiol. Biomarkers Prev., 11(5), 489-492.
104. Watanabe, J.; Shimada, T.; Gillam, E.M.; Ikuta, T.; Suemasu, K.; Higashi, Y.; Gotoh, O. and Kawajiri, K. (2000) Pharmacogenetics, 10(1), 25-33.
105. Zheng, W.; Xie, D.W.; Jin, F.; Cheng, J.R.; Dai, Q.; Wen, W.Q.; Shu, X.O. and Gao, Y.T. (2000) Cancer Epidemiol. Biomarkers Prev., 9(2), 147-150.
106. Kocabas, N.A.; Sardas, S.; Cholerton, S.; Daly, A.K. and Karakaya, A.E. (2002) Arch. Toxicol., 76(11), 643-649.
107. Tanaka, Y.; Sasaki, M.; Kaneuchi, M.; Shiina, H.; Igawa, M. and Dahiya, R. (2002) Biochem. Biophys. Res. Commun., 296(4), 820-826.
108. Tang, Y.M.; Green, B.L.; Chen, G.F.; Thompson, P.A.; Lang, N.P.; Shinde, A.; Lin, D.X.; Tan, W.; Lyn-Cook, B.D.; Hammons, G.J. and Kadlubar, F.F. (2000) Pharmacogenetics, 10(9), 761-766.
109. Ingelman-Sundberg, M. (2001) Mutat. Res., 482(1-2), 11-19.
110. Rao, Y.; Hoffmann, E.; Zia, M.; Bodin, L.; Zeman, M.; Sellers, E.M. and Tyndale, R.F. (2000) Mol. Pharmacol., 58(4), 747-755.
111. Oscarson, M. (2001) Drug Metab. Dispos., 29(2), 91-95.
112. Kitagawa, K.; Kunugita, N.; Kitagawa, M. and Kawamoto, T. (2001) J. Biol. Chem., 276(21), 17830-17835.
113. Xu, C.; Rao, Y.S.; Xu, B.; Hoffmann, E.; Jones, J.; Sellers, E.M. and Tyndale, R.F. (2002) Biochem. Biophys. Res. Commun, 290(1), 318-324.
114. Daigo, S.; Takahashi, Y.; Fujieda, M.; Ariyoshi, N.; Yamazaki, H.; Koizumi, W.; Tanabe, S.; Saigenji, K.; Nagayama, S.; Ikeda, K.; Nishioka, Y. and Kamataki, T. (2002) Pharmacogenetics, 12(4), 299-306.
115. Oscarson, M.; McLellan, R.A.; Asp, V.; Ledesma, M.; Ruiz, M.L.; Sinues, B.; Rautio, A. and Ingelman-Sundberg, M. (2002) Hum. Mutat., 20(4), 275-283.
116. Ingelman-Sundberg, M.; Oscarson, M. and McLellan, R.A. (1999) Trends. Pharmacol. Sci., 20(8), 342-349.
117. Ariyoshi, N.; Miyamoto, M.; Umetsu, Y.; Kunitoh, H.; Dosaka-Akita, H.; Sawamura, Y.; Yokota, J.; Nemoto, N.; Sato, K. and Kamataki, T. (2002) Cancer Epidemiol. Biomarkers Prev., 11(9), 890-894.
118. Miyamoto, M.; Umetsu, Y.; Dosaka-Akita, H.; Sawamura, Y.; Yokota, J.; Kunitoh, H.; Nemoto, N.; Sato, K.; Ariyoshi, N. and Kamataki, T. (1999) Biochem. Biophys. Res. Commun., 261(3), 658-660.
119. Tan, W.; Chen, G.F.; Xing, D.Y.; Song, C.Y.; Kadlubar, F.F. and Lin, D.X. (2001) Int. J. Cancer, 95(2), 96-101.
120. London, S.J.; Idle, J.R.; Daly, A.K. and Coetzee, G.A. (1999) Lancet., 353(9156), 898-899.
121. Loriot, M.A.; Rebuissou, S.; Oscarson, M.; Cenee, S.; Miyamoto, M.; Ariyoshi, N.; Kamataki T.; Hemon, D.; Beaune, P. and Stucker, I. (2001) Pharmacogenetics, 11 (1), 39-44.
122. Nakajima, M.; Kuroiwa, Y. and Yokoi, T. (2002) Drug. Metab. Rev., 34(4), 865-877.
123. Tyndale, R.F. and Sellers, E.M. (2002) Ther. Drug. Monit., 24(1), 163-171.
124. Topcu, Z.; Chiba, I.; Fujieda, M.; Shibata, T.; Ariyoshi, N.; Yamazaki, H.; Sevgican, F.; Muthumala, M.; Kobayashi, H. and Kamataki, T. (2002) Carcinogenesis, 23(4), 595-598.
125. Nowell, S.; Sweeney, C.; Hammons, G.; Kadlubar, F.F. and Lang, N.P. (2002) Cancer Epidemiol. Biomarkers Prev., 11(4), 377-383.
126. Gullsten, H.; Agundez, J.A.; Benitez, J.; Laara, E.; Ladero, J.M.; Diaz-Rubio, M.; Fernandez, P.; Gonzalez, F.; Rautio, A.; Pelkonen, O. and Raunio, H. (1997) Pharmacogenetics, 7(3), 247-250.
127. Tsukino, H.; Kuroda, Y.; Qiu, D.; Nakao, H.; Imai, H. and Katoh, T. (2002) Int. J. Cancer, 100(4), 425-428.
128. Lang, T.; Klein, K.; Fischer, J.; Nussler, A.K.; Neuhaus, P.; Hofmann, U.; Eichelbaum, M.; Schwab, M. and Zanger, U.M. (2001) Pharmacogenetics, 11(5), 399-415.
129. Roy, P.; Yu, L.J.; Crespi, C.L. and Waxman, D.J. (1999) Drug. Metab. Dispos., 27(6), 655-666.
130. Jounaidi, Y.; Hecht, J.E. and Waxman, D.J. (1998) Cancer Res., 58(19), 4391-4401.
131. Kan, O.; Griffiths, L.; Baban, D.; Iqball, S.; Uden, M.; Spearman, H.; Slingsby, J.; Price, T.; Esapa, M.; Kingsman, S.; Kingsman, A.; Slade, A. and Naylor, S. (2001) Cancer Gene. Ther., 8(7), 473-482.
132. Hukkanen, J.; Pelkonen, O.; Hakkola, J. and Raunio, H. (2002) Crit. Rev. Toxicol., 32(5), 391-411.
133. Iscan, M.; Klaavuniemi, T.; Coban, T.; Kapucuoglu, N.; Pelkonen, O. and Raunio, H. (2001) Breast. Cancer Res. Treat., 70(1), 47-54.
134. Lechevrel, M.; Casson, A.G.; Wolf, C.R.; Hardie, L.J.; Flinterman, M.B.; Montesano, R. and Wild, C.P. (1999) Carcinogenesis, 20(2), 243-248.
135. Vasquez, H.G. and Strobel, H. (1998) Int. J. Oncol., 12(6), 1291-1294.
136. Dai, D.; Zeldin, D.C.; Blaisdell, J.A.; Chanas, B.; Coulter, S.J.; Ghanayem, B.I. and Goldstein, J.A. (2001) Pharmacogenetics, 11(7), 597-607.
137. Bahadur, N.; Leathart, J.B.; Mutch, E.; Steimel-Crespi, D.; Dunn, S.A.; Gilissen, R.; Houdt, I.V.; Hendrickx, J.; Mannens, G.; Bohets, H.; Williams, F.M.; Armstrong, M.; Crespi, C.L. and Daly, A.K. (2002) Biochem. Pharmacol., 64 (11), 1579-1589.
138. Nakajima, M.; Fujiki, Y.; Noda, K.; Ohtsuka, H.; Ohkuni, H.; Kyo, S.; Inoue, M.; Kuroiwa, Y. and Yokoi, T. (2003) Drug. Metab. Dispos., 31(6), 687-690.
139. Yasar, U.; Lundgren, S.; Eliasson, E.; Bennet, A.; Wiman, B.; de Faire, U. and Rane, A. (2002) Biochem. Biophys. Res. Commun., 299(1), 25-28.
140. Garcia-Martin, E.; Martinez, C.; Garcia-Gamito, F.J.; Blanco, G. and Agundez, J.A. (2003) Meth. Find. Exp. Clin. Pharmacol., 25(Suppl. A), 111.
141. Xie, H.C.; Prasad, H.C.; Kim, R.B. and Stein, C.M. (2002) Adv. Drug. Deliv. Rev., 54(10), 1257-1270.
142. London, S.J.; Sullivan-Klose, T.; Daly, A.K. and Idle, J.R. (1997) Pharmacogenetics, 7(5), 401-404.
143. Ozawa, S.; Schoket, B.; McDaniel, L.P.; Tang, Y.M.; Ambrosone, C.B.; Kostic, S.; Vincze, I. and Kadlubar, F.F. (1999) Carcinogenesis, 20(6), 991-995.
144. Garcia-Martin, E.; Martinez, C.; Ladero, J.M.; Gamito, F.J.; Rodriguez-Lescure, A. and Agundez, J.A. (2002) Cancer Lett., 180(1), 41-46.
145. Bigler, J.; Whitton, J.; Lampe, J.W.; Fosdick, L.; Bostick, R.M. and Potter, J.D. (2001) Cancer Res., 61(9), 3566-3569.
146. Martinez, C.; Garcia-Martin, E.; Ladero, J.M.; Sastre, J.; Garcia-Gamito, F.; Diaz-Rubio, M. and Agundez, J.A. (2001) Carcinogenesis, 22(8), 1323-1326.
147. Kubota, T.; Hibi, N. and Chiba, K. (1998) Biochem. Pharmacol., 55(12), 2039-2042.
148. De Morais, S.M.; Wilkinson, G.R.; Blaisdell, J.; Nakamura, K.; Meyer, U.A. and Goldstein, J.A. (1994) J. Biol. Chem., 269(22), 15419-15422.
149. Ibeanu, G.C.; Goldstein, J.A.; Meyer, U.; Benhamou, S.; Bouchardy, C.; Dayer, P.; Ghanayem, B.I. and Blaisdell, J. (1998) J. Pharmacol. Exp. Ther., 286(3), 1490-1495.
150. De Morais, S.M.; Wilkinson, G.R.; Blaisdell, J.; Meyer, U.A.; Nakamura, K. and Goldstein, J.A. (1994) Mol. Pharmacol., 46(4), 594-598.
151. Ferguson, R.J.; De Morais, S.M.; Benhamou, S.; Bouchardy C.; Blaisdell, J.; Ibeanu, G.; Wilkinson, G.R.; Sarich, T.C.; Wright J.M.; Dayer, P. and Goldstein, J.A. (1998) J. Pharmacol. Exp. Ther., 284(1), 356-361.
152. Ibeanu, G.C.; Blaisdell, J.; Ghanayem, B.L.; Beyeler, C.; Benhamou, S.; Bouchardy, C.; Wilkinson, G.R.; Dayer, P.; Daly, A.K. and Goldstein, J.A. (1998) Pharmacogenetics, 8(2), 129-135.
153. Ibeanu, G.C.; Blaisdell, J.; Ferguson, R.J.; Ghanayem, B.I.; Brosen, K.; Benhamou, S.; Bouchardy, C.; Wilkinson, G.R.; Dayer, P. and Goldstein, J.A. (1999) J. Pharmacol. Exp. Ther., 290(2), 635-640.
154. Wadelius, M.; Autrup, J.L.; Stubbins, M.J.; Andersson, S.O.; Johansson, J.E.; Wadelius, C.; Wolf, C.R.; Autrup, H. and Rane, A. (1999) Pharmacogenetics, 9(3), 333-340.
155. Tsuneoka, Y.; Fukushima, K.; Matsuo, Y.; Ichikawa, Y. and Watanabe, Y. (1996) Life Sci., 59(20), 1711-1715.
156. Chau, T.K.; Marakami, S.; Kawai, B.; Nasu, K.; Kubota, T. and Ohnishi, A. (2000) Life Sci., 67(14), 1719-1724.
157. Ayesh, R.; Idle, J.R.; Ritchie, J.C.; Crothers, M.J. and Hetzel, M.R. (1984) Nature, 312(5990), 169-170.
158. Rostami-Hodjegan, A.; Lennard, M.S.; Woods, H.F. and Tucker, G.T. (1998) Pharmacogenetics, 8(3), 227-238.
159. Laforest, L.; Wikman, H.; Benhamou, S.; Saarikoski, S.T.; Bouchardy, C.; Hirvonen, A.; Dayer, P. and Husgafvel-Pursiainen, K. (2000) Eur. J. Cancer, 36(14), 1825-1832.
160. Leathart, J.B.; London, S.J.; Steward, A.; Adams, J.D.; Idle, J.R. and Daly, A.K. (1998) Pharmacogenetics, 8(6), 529-541.
161. Shaw, G.L.; Falk, R.T.; Frame, J.N.; Weiffenbach, B.; Nesbitt, J.C.; Pass, H.I.; Caporaso, N.E.; Moir, D.T. and Tucker, M.A. (1998) Cancer Epidemiol. Biomarkers Prev., 7(3), 215-219.
162. Legrand-Andreoletti, M.; Stucker, I.; Marez, D.; Galais, P.; Cosme, J.; Sabbagh, N.; Spire, C.; Cenee, S.; Lafitte, J.J.; Beaune, P. and Broly, F. (1998) Pharmacogenetics, 8(1), 7-14.
163. Legrand, M.; Stucker, I.; Marez, D.; Sabbagh, N.; Lo-Guidice, J.M. and Broly, F. (1996) Carcinogenesis, 17(10), 2267-2269.
164. Agundez, J.A.; Gallardo, L.; Ledesma, M.C.; Lozano, L.; Rodriguez-Lescure, A.; Pontes, J.C.; Iglesias-Moreno, M.C.; Poch, J.; Ladero, J.M. and Benitez, J. (2001) Oncology, 61(1), 59-63.
165. Gao, Y. and Zhang, Q. (1999) Mutat. Res., 444(2), 441-449.
166. London, S.J.; Daly, A.K.; Leathart, J.B.; Navidi, W.C.; Carpenter, C.C. and Idle, J.R. (1997) Carcinogenesis, 18(6), 1203-1214.
167. Agundez, J.A.; Martinez, C.; Ladero, J.M.; Ledesma, M.C.; Ramos, J.M.; Martin, R.; Rodriguez, A.; Jara, C. and Benitez, J. (1994) Clin. Pharmacol. Ther., 55(1), 10-14.
168. Shaw, G.L.; Weiffenbach, B.; Falk, R.T.; Frame, J.N.; Issaq, H.J.; Moir, D.T. and Caporaso, N. (1997) Lung Cancer, 17(1), 61-68.
169. Gronau, S.; Koenig Greger, D.; Jerg, M. and Riechelmann, H. (2002) Clin. Otolaryngol., 27(6), 453-457.
170. Topi, E.; Stefanovi, M.; Ivanisevi, A.M.; Petrinovi, R. and Curci, I. (2000) Clin. Chim. Acta, 296(1-2), 101-109.
171. Matthias, C.; Bockmuhl, U.; Jahnke, V.; Jones, P.W.; Hayes, J.D.; Alldersea, J.; Gilford, J.; Bailey, L.; Bath, J.; Worrall, S.F.; Hand, P.; Fryer, A.A. and Strange, R.C. (1998) Pharmacogenetics, 8(2), 91-100.
172. Benhamou, S.; Bouchardy, C.; Paoletti, C. and Dayer, P. (1996) Cancer Epidemiol. Biomarkers Prev., 5(9), 683-686.
173. Agundez, J.A.; Ledesma, M.C.; Benitez, J.; Ladero, J.M.; Rodriguez-Lescure, A.; Diaz-Rubio, E. and Diaz-Rubio, M. (1995) Lancet., 345(8953), 830-831.
174. Agundez, J.A.; Olivera, M.; Ladero, J.M.; Rodriguez-Lescure, A.; Ledesma, M.C.; Diaz-Rubio, M.; Meyer, U.A. and Benitez, J. (1996) Pharmacogenetics, 6 (6), 501-512.
175. Wolf, C.R.; Smith, C.A.; Gough, A.C.; Moss, J.E.; Vallis, K.A.; Howard, G.; Carey, F.J.; Mills, K.; McNee, W. and Carmichael, J. (1992) Carcinogenesis, 13(6), 1035-1038.
176. Dolzan, V.; Rudolf, Z. and Breskvar, K. (1995) Carcinogenesis, 16(11), 2675-2678.
177. Strange, R.C.; Ellison, T.; Ichii-Jones, F.; Bath, J.; Hoban, P.; Lear, J.T.; Smith, A.G.; Hutchinson, P.E.; Osborne, J.; Bowers, B.; Jones, P.W. and Fryer, A.A. (1999) Pharmacogenetics, 9(3), 269-276.
178. Krajinovic, M.; Labuda, D.; Mathonnet, G.; Labuda, M.; Moghrabi, A.; Champagne, J. and Sinnett, D. (2002) Clin. Cancer Res., 8(3), 802-810.
179. Infante-Rivard, C.; Labuda, D.; Krajinovic, M. and Sinnett, D. (1999) Epidemiology, 10(5), 481-487.
180. Sinnett, D.; Krajinovic, M. and Labuda, D. (2000) Leuk. Lymphoma., 38(5-6), 447-462.
181. Febbo, P.G.; Kantoff, P.W.; Giovannucci, E.; Brown, M.; Chang, G.; Hennekens, C.H. and Stampfer, M. (1998) Cancer Epidemiol. Biomarkers Prev., 7(12), 1075-1078.
182. Agundez, J.A.; Martinez, C.; Olivera, M.; Gallardo, L.; Ladero, J.M.; Rosado, C.; Prados, J.; Rodriguez-Molina, J.; Resel, L. and Benitez, J. (1998) Br. J. Cancer. 78(10), 1361-1367.
183. Anwar, W.A.; Abdel-Rahman, S.Z.; El-Zein, R.A.; Mostafa, H.M. and Au, W.W. (1996) Carcinogenesis. 17(9), 1923-1929.
184. Chinegwundoh, F.I. and Kaisary, A.V. (1996) Br. J. Urol., 77(5), 672-675.
185. Kelsey, K.T.; Wrensch, M.; Zuo, Z.F.; Miike, R. and Wiencke, J.K. (1997) Pharmacogenetics, 7(6), 463-468.
186. Elexpuru-Camiruaga, J.; Buxton, N.; Kandula, V.; Dias, P.S.; Campbell, D.; McIntosh, J.; Broome, J.; Jones, P.; Inskip, A. and Alldersea, J. (1995) Cancer Res., 55(19), 4237-4239.
187. Wundrack, I.; Meese, E.; Mullenbach, R. and Blin, N. (1994) Acta. Neuropathol. (Berl), 88(5), 472-474.
188. Gallou, C.; Longuemaux, S.; Delomenie, C.; Mejean, A.; Martin, N.; Martinet, S.; Palais, G.; Bouvier, R.; Droz, D.; Krishnamoorthy, R.; Junien, C.; Beroud, C. and Dupret, J.M. (2001) Pharmacogenetics, 11(6), 521-535.
189. Butler, W.J.; Ryan, P. and Roberts-Thomson, I.C. (2001) J. Gastroenterol. Hepatol., 16(6), 631-635.
190. Pontin, J.E.; Hamed, H.; Fentiman, I.S. and Idle, J.R. (1990) Eur. J. Cancer, 26(7), 790-792.
191. Ladero, J.M.; Benitez, J.; Jara, C.; Llerena, A.; Valdivielso, M.J.; Munoz, J.J. and Vargas, E. (1991) Oncology, 48(2), 107-110.
192. Huober, J.; Bertram, B.; Petru, E.; Kaufmann, M. and Schmahl, D. (1991) Breast Cancer Res. Treat., 18(1), 43-48.
193. Ladona, M.G.; Abildua, R.E.; Ladero, J.M.; Roman, J.M.; Plaza, M.A,; Agundez, J.A.; Munoz, J.J. and Benitez, J. (1996) Cancer Lett., 99(1), 23-28.
194. Smith, C.A.; Moss, J.E.; Gough, A.C.; Spurr, N.K. and Wolf, C.R. (1992) Environ Health Perspect, 98), 107-112,
195. Buchert, E.T.; Woosley, R.L.; Swain, S.M.; Oliver, S.J.; Coughlin, S.S.; Pickle, L.; Trock, B. and Riegel, A.T. (1993) Pharmacogenetics, 3(6), 322-327.
196. Lemos, M.C.; Cabrita, F.J.; Silva, H.A.; Vivan, M.; Placido, F. and Regateiro, F.J. (1999) Carcinogenesis, 20(7), 1225-1229.
197. Bryan, E.J.; Thomas, N.A.; Palmer, K.; Dawson, E.; Englefield, P. and Campbell, I.G. (2000) Int. J. Cancer, 87(6), 798-802.
198. Sarhanis, P.; Redman, C.; Perrett, C.; Brannigan, K.; Clayton, R.N.; Hand, P.; Musgrove, C.; Suarez, V.; Jones, P.; Fryer, A.A.; Farrell, W.E. and Strange, R.C. (1996) Br. J. Cancer, 74(11), 1757-1761.
199. Chen, C.; Cook, L.S.; Li, X.Y.; Hallagan, S.; Madeleine, M.M.; Daling, J.R. and Weiss, N.S. (1999) Cancer Epidemiol. Biomarkers Prev.; 8(4 Pt 1), 317-321.
200. Warwick, A.P.; Redman, C.W.; Jones P.W.; Fryer, A.A.; Gilford, J.; Alldersea, J. and Strange, R.C. (1994) Br. J. Cancer. 70(4), 704-708.
201. Perrett, C.W.; Clayton, R.N.; Pistorello, M.; Boscaro, M.; Scanarini, M.; Bates, A.S.; Buckley, N.; Jones, P.; Fryer, A.A. and Gilford, J. (1995) Carcinogenesis, 16(7), 1643-1645.
202. Hu, Y.; Oscarson, M.; Johansson, I.; Yue, Q.Y.; Dahl, M.L.; Tabone, M.; Arinco, S.; Albano, E. and Ingelman-Sundberg, M. (1997) Mol. Pharmacol, 51(3), 370-376.
203. Fairbrother, K.S.; Grove, J.; de Waziers, I.; Steimel, D.T.; Day, C.P.; Crespi, C.L. and Daly, A.K. (1998) Pharmacogenetics, 8(6), 543-552.
204. Yang, M.; Coles, B.F.; Delongchamp, R.; Lang, N.P. and Kadlubar, F.F. (2002) Lung Cancer, 38(1), 15-21.
205. Crawford, E.L.; Weaver, D.A.; DeMuth, J.P.; Jackson, C.M.; Khuder, S.A.; Frampton, M.W.; Utell, M.J.; Thilly, W.G. and Willey, J.C. (1998) Carcinogenesis, 19(10), 1867-1871.
206. Li, Z.; Tan, W. and Shao, K. (2000) Zhonghua. Zhong. Liu. Za. Zhi., 22(1), 5-7.
207. Wang, S.L.; Lee, H.; Chen, K.W.; Tsai, K.J.; Chen, C.Y. and Lin, P. (1999) Lung Cancer, 26(1), 27-34.
208. Le Marchand, L.; Sivaraman, L.; Pierce, L.; Seifried, A.; Lum, A.; Wilkens, L.R. and Lau, A.F. (1998) Cancer Res., 58(21), 4858-4863.
209. Wu, X.; Amos, C.I.; Kemp, B.L.; Shi, H.; Jiang, H.; Wan, Y. and Spitz, M.R. (1998) Cancer Epidemiol. Biomarkers Prev., 7(1), 13-18.
210. Oyama, T.; Kawamoto, T.; Mizoue, T.; Sugio, K.; Kodama, Y.; Mitsudomi, T. and Yasumoto, K. (1997) Anti. Cancer Res., 17(1B), 583-587.
211. El-Zein, R.A.; Zwischenberger, J.B.; Abdel-Rahman, S.Z.; Sankar, A.B. and Au, W.W. (1997) Cancer Lett., 112(1), 71-78.
212. Uematsu, F.; Ikawa, S.; Kikuchi, H.; Sagami, I.; Kanamaru, R.; Abe, T.; Satoh, K.; Motomiya, M. and Watanabe, M. (1994) Pharmacogenetics, 4(2), 58-63.
213. Quinones, L.; Lucas, D.; Godoy, J.; Caceres, D.; Berthou, F.; Varela, N.; Lee, K.; Acevedo, C.; Martinez, L.; Aguilera, A.M. and Gil, L. (2001) Cancer Lett., 174(1), 35-44.
214. Persson, I.; Johansson, I.; Lou, Y.C.; Yue, Q.Y.; Duan, L.S.; Bertilsson, L. and Ingelman-Sundberg, M. (1999) Int. J. Cancer, 81(3), 325-329.
215. London, S.J.; Daly, A.K.; Cooper, J.; Carpenter, C.L.; Navidi, W.C.; Ding, L. and Idle, J.R. (1996) Pharmacogenetics, 6(2), 151-158.
216. Watanabe, J.; Yang, J.P.; Eguchi, H.; Hayashi, S.; Imai, K.; Nakachi, K. and Kawajiri, K. (1995) Jpn. J. Cancer Res., 86(3), 245-248.
217. Hamada, G.S.; Sugimura, H.; Suzuki, I.; Nagura, K.; Kiyokawa, E.; Iwase, T.; Tanaka, M.; Takahashi, T.; Watanabe, S. and Kino, I. (1995) Cancer Epidemiol. Biomarkers Prev., 4(1), 63-67.
218. Hirvonen, A.; Husgafvel-Pursiainen, K.; Anttila, S.; Karjalainen, A. and Vainio, H. (1993) Carcinogenesis, 14(1), 85-88.
219. Kato, S.; Shields, P.G.; Caporaso, N.E.; Hoover, R.N.; Trump, B.F.; Sugimura, H.; Weston, A. and Harris, C.C. (1992) Cancer Res., 52(23), 6712-6715.
220. Hirvonen, A.; Husgafvel-Pursiainen, K.; Anttila, S.; Karjalainen, A.; Sorsa, M. and Vainio, H. (1992) Pharmacogenetics, 2(6), 259-263.
221. Tan, W.; Song, N.; Wang, G.Q.; Liu, Q.; Tang, H.J.; Kadlubar, F.F. and Lin, D.X. (2000) Cancer Epidemiol. Biomarkers Prev., 9(6), 551-556.
222. Lin, D.; Tang, Y. and Peng, Q. (1998) Zhonghua. Zhong. Liu. Za. Zhi., 20(2), 94-97.
223. Gao, C.; Takezaki, T.; Wu, J.; Li, Z.; Wang, J.; Ding, J.; Liu, Y.; Hu, X.; Xu, T.; Tajima, K. and Sugimura, H. (2002) Cancer Epidemiol. Biomarkers Prev., 11(1), 29-34.
224. Chao, Y.C.; Wang, L.S.; Hsieh, T.Y.; Chu, C.W.; Chang, F.Y. and Chu, H.C. (2000) Am. J. Gastroenterol, 95(10), 2958-2964.
225. Wu, M.S.; Chen, C.J.; Lin, M.T.; Wang, H.P.; Shun, C.T.; Sheu, J.C. and Lin, J.T. (2002) Int. J. Colorectal. Dis., 17(5), 338-343.
226. Nishimoto, I.N.; Hanaoka, T.; Sugimura, H.; Nagura, K.; Ihara, M.; Li, X.J.; Arai, T.; Hamada, G.S.; Kowalski, L.P. and Tsugane, S. (2000) Cancer Epidemiol. Biomarkers Prev., 9(7), 675-680.
227. Cai, L.; Yu, S.Z. and Zhan, Z.F. (2001) World J. Gastroenterol., 7(6), 792-795.
228. Kato, S.; Onda, M.; Matsukura, N.; Tokunaga, A.; Matsuda, N.; Yamashita, K. and Shields, P.G. (1997) Biomed. Pharmacother., 51(4), 145-149.
229. Kato, S.; Shields, P.G.; Caporaso, N.E.; Sugimura, H.; Trivers, G.E.; Tucker, M.A.; Trump, B.F.; Weston, A. and Harris, C.C. (1994) Cancer Epidemiol. Biomarkers Prev., 3(6), 515-518.
230. Yu, M.W.; Gladek-Yarborough, A.; Chiamprasert, S.; Santella, R.M.; Liaw, Y.F. and Chen, C.J. (1995) Gastroenterology, 109(4), 1266-1273.
231. Farker, K.; Schotte, U.; Scheele, J. and Hoffmann, A. (2002) Int. J. Clin. Pharmacol. Ther., 40(3), 120-124.
232. Lee, H.S.; Yoon, J.H.; Kamimura, S.; Iwata, K.; Watanabe, H. and Kim, C.Y. (1997) Int. J. Cancer, 71(5), 737-740.
233. Ladero, J.M.; Agundez, J.A.; Rodriguez-Lescure, A.; Diaz-Rubio, M. and Benitez, J. (1996) Gut, 39(2), 330-333.
234. Le Marchand, L.; Donlon, T.; Seifried, A. and Wilkens, L.R. (2002) Cancer Epidemiol. Biomarkers Prev., 11(10 Pt 1), 1019-1024.
235. Liu, S.; Park, J.Y.; Schantz, S.P.; Stern, J.C. and Lazarus, P. (2001) Oral. Oncol., 37(5), 437-445.
236. Kongruttanachok, N.; Sukdikul, S.; Setavarin, S.; Kerekhjanarong, V.; Supiyaphun, P.; Voravud, N.; Poovorawan, Y. and Mutirangura, A. (2001) BMC Cancer, 1(1), 4.
237. Bouchardy, C.; Hirvonen, A.; Coutelle, C.; Ward, P.J.; Dayer, P. and Benhamou, S. (2000) Int. J. Cancer, 87(5), 734-740.
238. Hildesheim, A.; Anderson, L.M.; Chen, C.J.; Cheng, Y.J.; Brinton, L.A.; Daly, A.K.; Reed, C.D.; Chen, I.H.; Caporaso, N.E.; Hsu, M.M.; Chen, J.Y.; Idle, J.R.; Hoover, R.N.; Yang, C.S. and Chhabra, S.K. (1997) J. Natl. Cancer Inst., 89(16), 1207-1212.
239. Matthias, C.; Jahnke, V.; Jones, P.W.; Hoban, P.R.; Alldersea, J.E.; Worrall, S.F.; Fryer, A.A. and Strange, R.C. (1999) Cancer Epidemiol. Biomarkers Prev., 8(9), 815-823.
240. Hung, H.C.; Chuang, J.; Chien, Y.C.; Chern, H.D.; Chiang, C.P.; Kuo, Y.S.; Hildesheim, A. and Chen, C.J. (1997) Cancer Epidemiol. Biomarkers Prev., 6(11), 901-905.
241. Jahnke, V.; Matthias, C.; Fryer, A. and Strange, R. (1996) Am. J. Surg., 172(6), 671-673.
242. Sierra-Torres, C.H.; Au, W.W.; Arrastia, C.D.; Cajas-Salazar, N.; Robazetti, S.C.; Payne, D.A. and Tyring, S.K. (2003) Environ. Mol. Mutagen., 41(1), 69-76.
243. De Roos, A.J.; Rothman, N.; Inskip, P.D.; Linet, M.S.; Shapiro, W.R.; Selker, R.G.; Fine, H.A.; Black, P.M.; Pittman, G.S. and Bell, D.A. (2003) Cancer Epidemiol. Biomarkers Prev., 12(1), 14-22.
244. Farker, K.; Lehmann, M.H.; Kastner, R.; Weber, J.; Janitzky, V.; Schubert, J. and Hoffmann, A. (2000) Int. J. Clin. Pharmacol. Ther., 38(1), 30-34.
245. Farker, K.; Lehmann, M.H.; Oelschlagel, B.; Haerting, J.; Hoffmann, A.; Janitzky, V. and Schubert, J. (1998) Exp. Toxicol. Pathol., 50(4-6), 425-431.
246. Shields, P.G.; Ambrosone, C.B.; Graham, S.; Bowman, E.D.; Harrington, A.M.; Gillenwater, K.A.; Marshall, J.R.; Vena, J.E.; Laughlin, R.; Nemoto, T. and Freudenheim, J.L. (1996) Mol. Carcinog., 17(3), 144-150.
247. Sata, F.; Sapone, A.; Elizondo, G.; Stocker, P.; Miller, V.P.; Zheng, W.; Raunio, H.; Crespi, C.L. and Gonzalez, F.J. (2000) Clin. Pharmacol. Ther., 67(1), 48-56.
248. Hsieh, K.P.; Lin, Y.Y.; Cheng, C.L.; Lai, M.L.; Lin, M.S.; Siest, J.P. and Huang, J.D. (2001) Drug Metab. Dispos., 29(3), 268-273.
249. Eiselt, R.; Domanski, T.L.; Zibat, A.; Mueller, R.; Presecan-Siedel, E.; Hustert, E.; Zanger, U.M.; Brockmoller, J.; Klenk, H.P.; Meyer, U.A.; Khan, K.K.; He, Y.A.; Halpert, J.R. and Wojnowski, L. (2001) Pharmacogenetics, 11 (5), 447-458.
250. Lamba, J.K.; Lin, Y.S.; Thummel, K.; Daly, A.; Watkins, P.B.; Strom, S.; Zhang, J. and Schuetz, E.G. (2002) Pharmacogenetics, 12(2), 121-132.
251. Dai, D.; Tang, J.; Rose, R.; Hodgson, E.; Bienstock, R.J.; Mohrenweiser, H.W. and Goldstein, J.A. (2001) J. Pharmacol. Exp. Ther., 299(3), 825-831.
252. Garcia-Martin, E.; Martinez, C.; Pizarro, R.M.; Garcia-Gamito, F.J.; Gullsten, H.; Raunio, H. and Agundez, J.A. (2002) Clin. Pharmacol. Ther., 71(3), 196-204.
253. Finnstrom, N.; Bjelfman, C.; Soderstrom, T.G.; Smith, G.; Egevad, L.; Norlen, B.J.; Wolf, C.R. and Rane, A. (2001) Eur. J. Clin. Invest., 31(10), 880-886.
254. Huang, Z.; Fasco, M.J.; Figge, H.L.; Keyomarsi. K. and Kaminsky, L.S. (1996) Drug. Metab. Dispos., 24(8), 899-905.
255. Huang, Z.; Guengerich, F.P. and Kaminsky, L.S. (1998) Carcinogenesis, 19(5), 867-872.
256. Tayeb, M.T.; Clark, C.; Haites, N.E.; Sharp, L.; Murray, G.I. and McLeod, H.L. (2003) Br. J. Cancer, 88(6), 928-932.
257. Kittles, R.A.; Chen, W.; Panguluri, R.K.; Ahaghotu, C.; Jackson, A.; Adebamowo, C.A.; Griffin, R.; Williams, T.; Ukoli, F.; Adams-Campbell, L.; Kwagyan, J.; Isaacs, W.; Freeman, V. and Dunston, G.M. (2002) Hum. Genet., 110(6), 553-560.
258. Paris, P.L.; Kupelian, P.A.; Hall, J.M.; Williams, T.L.; Levin, H.; Klein, E.A.; Casey, G. and Witte, J.S. (1999) Cancer Epidemiol. Biomarkers Prev., 8(10), 901-905.
259. Ando, Y.; Tateishi, T.; Sekido, Y.; Yamamoto, T.; Satoh, T.; Hasegawa, Y.; Kobayashi, S.; Katsumata, Y.; Shimokata, K. and Saito, H. (1999) J. Natl. Cancer Inst., 91(18), 1587-1590.
260. Rebbeck, T.R.; Jaffe, J.M.; Walker, A.H.; Wein, A.J. and Malkowicz, S.B. (1998) J. Natl. Cancer Inst., 90(16), 1225-1229.
261. Spurdle, A.B.; Goodwin, B.; Hodgson, E.; Hopper, J.L.; Chen, X.; Purdie, D.M.; McCredie, M.R.; Giles, G.G.; Chenevix-Trench, G. and Liddle, C. (2002) Pharmacogenetics, 12(5), 355-366.
262. Westlind, A.; Lofberg, L.; Tindberg, N.; Andersson, T.B. and Ingelman-Sundberg, M. (1999) Biochem. Biophys. Res. Commun., 259(1), 201-205.
263. Lamba, J.K.; Lin, Y.S.; Schuetz, E.G. and Thummel, K.E. (2002) Adv. Drug Deliv. Rev., 54(10), 1271-1294.
264. Blanco, J.G.; Edick, M.J.; Hancock, M.L.; Winick, N.J.; Dervieux, T.; Amylon, M.D.; Bash, R.O.; Behm, F.G.; Camitta, B.M.; Pui, C.H.; Raimondi, S.C. and Relling, M.V. (2002) Pharmacogenetics. 12(8), 605-611.
265. Jounaidi, Y.; Hyrailles, V.; Gervot, L. and Maurel, P. (1996) Biochem. Biophys. Res. Commun., 221(2), 466-470.
266. Kuehl, P.; Zhang, J.; Lin, Y.; Lamba, J.; Assem, M.; Schetz, J.; Watkins, P.B.; Daly, A.; Wrighton, S.A.; Hall, S.D.; Maurel, P.; Relling, M.; Brimer, C.; Yasuda, K.; Venkataramanan, R.; Strom, S.; Thummel, K.; Boguski, M.S. and Schuetz, E. (2001) Nat. Genet., 27(4), 383-391.
267. Hustert, E.; Haberl, M.; Burk, O.; Wolbold, R.; He, Y.Q.; Klein, K.; Nuessler, A.C.; Neuhaus, P.; Klattig, J.; Eiselt, R.; Koch, I.; Zibat, A.; Brockmoller, J.; Halpert, J.R.; Zanger, U.M. and Wojnowski, L. (2001) Pharmacogenetics, 11(9), 773-779.
268. Chou, F.C.; Tzeng, S.J. and Huang, J.D. (2001) Drug Metab. Dispos., 29 (9), 1205-1209.
269. Liu, T.C.; Lin, S.F.; Chen, T.P. and Chang, J.G. (2002) Oncol. Rep., 9(2), 327-9.
270. Kondoh, N.; Wakatsuki, T.; Ryo, A.; Hada, A.; Aihara, T.; Horiuchi, S.; Goseki, N.; Matsubara, O.; Takenaka, K.; Shichita, M.; Tanaka, K.; Shuda, M. and Yamamoto. M. (1999) Cancer Res., 59(19), 4990-4996.
271. Chevalier, D.; Cauffiez, C.; Bernard, C.; Lo-Guidice, J.M.; Allorge, D.; Fazio, F.; Ferrari, N.; Libersa, C.; Lhermitte, M.; D'Halluin, J.C. and Broly, F. (2001) Hum. Genet., 108(2), 148-155.
272. Patocs, A.; Toth, M.; Barta, C.; Sasvari-Szekely, M.; Varga, I.; Szucs, N.; Jakab, C.; Glaz, E. and Racz, K. (2002) Eur. J. Endocrinol., 147(3), 349-355.
273. Stikkelbroeck, N.M.; Otten, B.J.; Pasic, A.; Jager, G.J.; Sweep, C.G.; Noordam, K. and Hermus, A.R. (2001) J. Clin. Endocrinol. Metab., 86(12), 5721-5728.
274. Witchel, S.F. and Aston, C.E. (2000) J. Pediatr. Endocrinol. Metab., 13 (Suppl. 5), 1315-1317.
275. Kjellman, M.; Holst, M.; Backdahl, M.; Larsson, C.; Farnebo, L.O. and Wedell, A. (1999) Clin. Endocrinol. (Oxf), 50(3), 343-346.
276. Agundez, J.A.; Rodriguez, I.; Olivera, M.; Ladero, J.M.; Garcia, M.A.; Ribera, J.M. and Benitez, J. (1997) Age Ageing, 26(2), 147-151.
277. Taioli, E.; Mari, D.; Franceschi, C.; Bonafe, M.; Monti, D.; Bertolini, S.; Marinelli, D. and Garte, S. (2001) Biochem. Biophys. Res. Commun., 280(5), 1389-1392.
278. Bathum, L.; Andersen-Ranberg, K.; Boldsen, J.; Brosen, K. and Jeune, B. (1998) Eur. J. Clin. Pharmacol., 54(5), 427-430.
279. Muiras, M.L.; Verasdonck, P.; Cottet, F. and Schachter F. (1998) Hum. Genet., 102(5), 526-532.
280. Agundez, J.A. (2003) J. Appl. Res., 3(2), 118-123.
281. Brennan, P. (2002) Carcinogenesis, 23(3), 381-387.